Sabhapandit Swapnali, Abdussamad Afra, Shaik Tummala Arifa, Perumalla Solomon Raju
Institute of Ophthalmic Sciences, Asian Institute of Gastroenterology Hospitals, Hyderabad, Telangana, India.
Clin Ophthalmol. 2023 May 30;17:1497-1504. doi: 10.2147/OPTH.S415636. eCollection 2023.
Transepithelial photorefractive keratectomy (Trans PRK) is a relatively new technology for refractive surgery and has shown promising results in myopia correction. The data on hyperopia correction by this method are limited. In this review, we have attempted to understand the outcomes of this technology on hyperopic eyes. There are comparable results with conventional PRK and laser in situ keratomileusis (LASIK) as far as refractive stability, regression rate, predictability, and post-operative complications are concerned. The best results have been obtained in lower hyperopic corrections. In moderate to higher hyperopia, the limited data available show higher regression, unstable visual outcomes, and increased stromal haze. There is a need to evaluate the technology further to understand its success for hyperopic refractive surgery.
经上皮准分子激光角膜切削术(Trans PRK)是一种相对较新的屈光手术技术,在近视矫正方面已显示出有前景的结果。关于该方法矫正远视的数据有限。在本综述中,我们试图了解该技术在远视眼中的效果。就屈光稳定性、回退率、可预测性和术后并发症而言,与传统的准分子激光角膜切削术(PRK)和准分子原位角膜磨镶术(LASIK)有可比的结果。在较低度数的远视矫正中取得了最佳效果。在中度至高度远视中,现有的有限数据显示回退率更高、视觉效果不稳定以及基质 haze 增加。需要进一步评估该技术,以了解其在远视屈光手术中的成功率。